M von Eynatten, JG Schneider, PM Humpert, G … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—Nondiabetic subjects with decreased plasma adiponectin had lower LPL activity
(r = 0.42, P < 0.0001). This association of plasma adiponectin with LPL activity was confirmed
in the second group of patients with type 2 diabetes (r = 0.37, P < 0.0001). Multivariate ... Cited by 80 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org JG Schneider, M von Eynatten, S Schiekofer, PP … - Diabetes Care, 2005 - Am Diabetes Assoc OBJECTIVE—Hepatic lipase plays a key role in hydrolyzing triglycerides and phospholipids
present in circulating plasma lipoproteins. Plasma hepatic lipase activity is known to be regulated
by several hormonal and metabolic factors, but hepatic lipase responsiveness to insulin is ... Cited by 54 - Related articles - BL Direct - All 6 versions
- ►endojournals.org R Baratta, S Amato, C Degano, MG Farina, G … - Journal of Clinical …, 2004 - Endocrine Soc Considering all subjects both together and subdivided into nonobese (n = 107) and obese (n
= 135) groups, plasma adiponectin, but not plasma leptin, was significantly (P < 0.01) correlated
with insulin sensitivity [homeostasis model assessment of insulin-resistance index (HOMA ... Cited by 111 - Related articles - BL Direct - All 7 versions
J Kobayashi, M Kusunoki, Y Murase, M Kawashiri, … - Hormone and metabolic …, 2005 - cat.inist.fr Objective: The aim of this study was to determine how lipoprotein lipase(LPL) and hepatic triacylglycerol
lipase(HTGL) activity relate to serum adiponectin levels. Research design and methods:
Fifty-five hyperlipidemic Japanese men were recruited for this study. LPL and HTGL ... Cited by 11 - Related articles - BL Direct - All 4 versions
TW Ng, GF Watts, MS Farvid, DC Chan, PH Barrett - Diabetes, 2005 - theses.library.uwa.edu.au Adipocytokines and VLDL Metabolism Independent Regulatory Effects of Adiponectin, Insulin
Resistance, and Fat Compartments on VLDL Apolipoprotein B-100 Kinetics? Theodore WK
Ng,1 Gerald F. Watts,1 Maryam S. Farvid,1,2 Dick C. Chan,1 and P. Hugh E. Barrett1 we ... Cited by 54 - Related articles - All 5 versions
R De Vries, BH Wolffenbuttel, WJ Sluiter, A Van Tol, … - Clinical …, 2005 - ncbi.nlm.nih.gov The aim of this study was to determine the relationships of plasma adiponectin with post-heparin
plasma lipoprotein lipase (LPL) and hepatic lipase (HL) activities, and to evaluate whether plasma
adiponectin contributes to diabetes-associated dyslipidaemia. Plasma adiponectin, post- ... Cited by 10 - Related articles - BL Direct
RS Lindsay, HE Resnick, J Zhu, ML Tun, BV … - … , and vascular biology, 2005 - Am Heart Assoc Cases and controls were selected from the SHS cohort. 6 The SHS recruited 4549 volunteers
of American Indian heritage from 3 geographic areas (Arizona, North and South Dakota, and
Oklahoma). 6 Volunteers (59% female) were invited to a study examination on three ... Cited by 112 - Related articles - All 5 versions
- ►endojournals.org TP Combs, UB Pajvani, AH Berg, Y Lin, LA Jelicks, M … - Endocrinology, 2004 - Endocrine Soc Adiponectin is a plasma protein expressed exclusively in adipose tissue. Adiponectin levels
are linked to insulin sensitivity, but a direct effect of chronically elevated adiponectin on improved
insulin sensitivity has not yet been demonstrated. We identified a dominant mutation in ... Cited by 206 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org MB Schulze, I Shai, EB Rimm, T Li, N Rifai, FB Hu - Diabetes, 2005 - Am Diabetes Assoc Adiponectin, predominantly synthesized in the adipose tissue, seems to have substantial
anti-inflammatory properties and to be a major modulator of insulin resistance and
dyslipidemia, mechanisms that are associated with an increased atherosclerotic risk in ... Cited by 185 - Related articles - All 5 versions
